ICIs mainly bind to CTLA-4 and PD-1 receptors on the surface of T cells and to PD-L1 receptors on the surface of tumors to relieve the immunosuppression of T cells, thus killing tumor cells.178. Here, CTLA4 is linked to neoplasm.